Global Over The Counter & Remote Test For Covid-19 Market

Global Over The Counter & Remote Test For Covid-19 Market Size, Trends & Analysis - Forecasts to 2026 By Collection Method (Nasal Swab, Saliva Swab), By Distribution Channel (Pharmacy, Retail Stores, Online), By End-Use (Home Testing, Point-of-Care, Clinics), By Region (North America, Asia Pacific, Europe, Latin America, Middle East & Africa); End-User Landscape, Company Market Share Analysis, and Competitor Analysis

Category Healthcare

Format

This report was recently updated on November 16 2024 with the latest and most recent market numbers

Over The Counter & Remote Test For Covid-19 Market Insights

Extensive community spread of Covid-19 virus has led to the introduction of self testing kits in some countries. It is expected that Over The Counter & Remote Test For Covid-19 will be available in the majority of the countries by the end of 2021. The U.S., Germany, Austria, and UK are the leading countries to introduce and adopt this method.

As per current regulations in different countries, the rapid antigen detection tests are becoming available to non health practitioners as well. People can diagnose themselves through this test kit and do the needful as per their test findings i.e. positive or negative. The introduction and implementation of Over The Counter & Remote Test For Covid-19 came into existence to control the transmission and early detection of the virus in the people. Self testings are making it easier for people to take tests and isolate themselves at an early stage in case of positive results.

Affordable price, easy availability, and instant results are the major factors to drive the product demand. However, incompetence in the testing of antibodies may hinder the market in case of asymptomatic patients.

global over the counter & remote test for covid-19 market

Over The Counter & Remote Test For Covid-19 Market: By Collection Method

Nasal swab and saliva swab are two methods to collect the samples in Over The Counter & Remote Test kit For Covid-19. Nasal swab will dominate the industry owing to the wide presence of nasal swab based products availability in the market. Accuracy and easy methods are two factors to drive demand in this segment.

Over The Counter & Remote Test For Covid-19 Market: By Distribution Channel

Pharmacy, retail stores, and online are three distribution channels involved in the industry. Retail stores will attain the highest gains up to 2026. Government approval along with collaborations with the manufacturers are key factors to drive demand in this segment. CVS Pharmacies, Walmart stores, and Walgreens are three stores where the consumer can buy the kit without a prescription in the U.S.

Online channels will witness significant gains, but at the maturity stage of the market. Currently, the industry is struggling due to limited manufacturing and supply. Thus, the attainment of streamlined supplies in the later years will create opportunities in this segment.

Over The Counter & Remote Test For Covid-19 Market: By End-Use

By end-use, the market is grouped into home testing, point of care setting, and clinics. Home application will hold the maximum share in the coming years. Easy product availability along with no requirement of prescription makes it easier for consumers to get self tested. Moreover, a non complicated testing method accompanied by instant results in less than 20 minutes will make it easier for consumers to get assured and prevent the virus spread in the community.

The other promising end-user in this industry are the small scale clinics. Due to the health crisis the hospitals are packed and there is reluctance among consumers to visit hospitals for the minimal health concern. Thus, the introduction of these Over The Counter & Remote Test For Covid-19 makes it easier for clinics to instantly check the patient who is showing some symptoms of the virus infection.

asia pacific over the counter & remote test for covid-19 market

Over The Counter & Remote Test For Covid-19 Market: By Region

North America Over The Counter & Remote Test For Covid-19 dominated the overall regional share. FDA approvals along with presence of validated product offerings by domestic suppliers are key contributing factors to drive regional demand. Recently, FDA has approved three home testing kits which can be availed without prescription. Ellume, Abbott BinaxNow, and Pixel by Labcorp are three authorized home testing kits in the U.S. which can be purchased without prescription.

European market will witness substantial growth in the coming years. Consistent efforts to take every possible measure to control the pandemic along with emergence of home based kits by domestic diagnostic providers will positively influence the high adoption of Over The Counter & Remote Covid-19 Test in the region. Germany, Spain, Austria, UK, and France are among the major countries to implement these testing methods. Roche and Eurofins are key identified companies to invest in Germany.

Asia Pacific Over The Counter & Remote Test For Covid-19 will witness highest gains during the forecast period. Reluctant behaviour towards vaccines in developing countries along with faster mutation of the virus in some countries are major factors to drive the requirement of consistent testing solutions. Large number of population and adverse impact due to robust second wave in India has resulted in the introduction of multiple options to detect and treat the virus. In India, Mylab will be the first company to commercialize and sell the home based testing. The kits will hit the market by mid of 2021.

Over The Counter & Remote Test For Covid-19 Company Market Share and Competitor Analysis

Global Over The Counter & Remote Test For Covid-19 Company Market Share is in its nascent stage and development stage. Consistent new market entrant and changes in regulatory guidelines for specific product offering makes the market dynamic in nature. Approvals from the regulatory authorities to distribute products through different supply channels is another key aspect for the industry participants.

Quidel, Cue Health Inc., Lucira Health, Ellume Health, Abbott, Healgen Scientific, Xiamen Boson Biotech, Hangzhou Laihe Biotech, Eurofins, Megna Health, Therma Bright, My Health Checked, OraSure technologies, Roche, City Health, Trivitron, Mylab, Labcorp, and Nanomix, are key recognized companies in the industry.

Other notable players in the field of remote testing by providing facility to collect samples at home includes but not limited to EverlyWell, LetsGetChecked, Phosphorus, Hims & Hers, Picture by Fulgent Genetics, and Vitagene.

Please note: This is not an exhaustive list of companies profiled in the report.

Chapter 1 Methodology

1.1 Market scope & definitions

1.2 Estimates & forecast calculation

1.3 Historical data overview and validation

1.4 Data sources

1.4.1 Secondary

1.4.2 Primary

Chapter 2 Report Outlook

2.1 Over the counter & remote test for covid-19 industry overview, 2020-2026

2.1.1 Industry overview

2.1.2 Collection method overview

2.1.3 Distribution channel overview

2.1.4 End-use overview

2.1.5 Regional overview

Chapter 3 Over The Counter & Remote Test For Covid-19 Market Trends

3.1 Market segmentation

3.2 Industry background, 2020-2026

3.3 Market key trends

3.3.1 Positive trends

3.3.2 Industry challenges

3.4 Prospective growth scenario

3.5 COVID-19 influence over industry growth

3.6 Porter’s analysis

3.7 PESTEL analysis

3.8 Value chain & supply chain analysis

3.9 Regulatory framework

3.9.1 North America

3.9.2 Europe

3.9.3 APAC

3.9.4 LATAM

3.9.5 MEA

3.10 Technology overview

3.11 Market share analysis, 2020

3.11.1 Company positioning overview, 2020

Chapter 4 Over The Counter & Remote Test For Covid-19 Market, By Collection Method

4.1 Collection Method Outlook

4.2 Nasal Swab

4.2.1 Market size, by region, 2020-2026 (USD Million)

4.3 Saliva Swab

4.3.1 Market size, by region, 2020-2026 (USD Million)

Chapter 5 Over The Counter & Remote Test For Covid-19 Market, By Distribution Channel

5.1 Distribution Channel Outlook

5.2 Pharmacy

5.2.1 Market size, by region, 2020-2026 (USD Million)

5.3 Retail Stores

5.3.1 Market size, by region, 2020-2026 (USD Million)

5.4 Online

5.4.1 Market size, by region, 2020-2026 (USD Million)

Chapter 6 Over The Counter & Remote Test For Covid-19 Market, By End-Use

6.1 End-Use Outlook

6.2 Home testing

6.2.1 Market size, by region, 2020-2026 (USD Million)

6.3 Point of care settings

6.3.1 Market size, by region, 2020-2026 (USD Million)

6.4 Clinics

6.4.1 Market size, by region, 2020-2026 (USD Million)

Chapter 7 Over The Counter & Remote Test For Covid-19 Market, By Region

7.1 Regional outlook

7.2 North America

7.2.1 Market size, by country 2020-2026 (USD Million)

7.2.2 Market size, by collection method, 2020-2026 (USD Million)

7.2.3 Market size, by distribution channel, 2020-2026 (USD Million)

7.2.4 Market size, by end-use, 2020-2026 (USD Million)

7.2.5 U.S.

7.2.5.1 Market size, by collection method, 2020-2026 (USD Million)

7.2.5.2 Market size, by distribution channel, 2020-2026 (USD Million)

7.2.5.3 Market size, by end-use, 2020-2026 (USD Million)

7.2.6 Canada

7.2.6.1 Market size, by collection method, 2020-2026 (USD Million)

7.2.6.2 Market size, by distribution channel, 2020-2026 (USD Million)

7.2.6.3 Market size, by end-use, 2020-2026 (USD Million)

7.3 Europe

7.3.1 Market size, by country 2020-2026 (USD Million)

7.3.2 Market size, by collection method, 2020-2026 (USD Million)

7.3.3 Market size, by distribution channel, 2020-2026 (USD Million)

7.3.4 Market size, by end-use, 2020-2026 (USD Million)

7.3.5 Germany

7.2.5.1 Market size, by collection method, 2020-2026 (USD Million)

7.2.5.2 Market size, by distribution channel, 2020-2026 (USD Million)

7.2.5.3 Market size, by end-use, 2020-2026 (USD Million)

7.3.6 UK

7.3.6.1 Market size, by collection method, 2020-2026 (USD Million)

7.3.6.2 Market size, by distribution channel, 2020-2026 (USD Million)

7.3.6.3 Market size, by end-use, 2020-2026 (USD Million)

7.3.7 France

7.3.7.1 Market size, by collection method, 2020-2026 (USD Million)

7.3.7.2 Market size, by distribution channel, 2020-2026 (USD Million)

7.3.7.3 Market size, by end-use, 2020-2026 (USD Million)

7.3.8 Italy

7.3.8.1 Market size, by collection method, 2020-2026 (USD Million)

7.3.8.2 Market size, by distribution channel, 2020-2026 (USD Million)

7.3.8.3 Market size, by end-use, 2020-2026 (USD Million)

7.4 Asia Pacific

7.4.1 Market size, by country 2020-2026 (USD Million)

7.4.2 Market size, by collection method, 2020-2026 (USD Million)

7.4.3 Market size, by distribution channel, 2020-2026 (USD Million)

7.4.4 Market size, by end-use, 2020-2026 (USD Million)

7.4.5 China

7.4.5.1 Market size, by collection method, 2020-2026 (USD Million)

7.4.5.2 Market size, by distribution channel, 2020-2026 (USD Million)

7.4.5.3 Market size, by end-use, 2020-2026 (USD Million)

7.4.6 India

7.4.6.1 Market size, by collection method, 2020-2026 (USD Million)

7.4.6.2 Market size, by distribution channel, 2020-2026 (USD Million)

7.4.6.3 Market size, by end-use, 2020-2026 (USD Million)

7.4.7 Japan

7.4.7.1 Market size, by collection method, 2020-2026 (USD Million)

7.4.7.2 Market size, by distribution channel, 2020-2026 (USD Million)

7.4.7.3 Market size, by end-use, 2020-2026 (USD Million)

7.4.8 Australia

7.4.8.1 Market size, by collection method, 2020-2026 (USD Million)

7.4.8.2 Market size, by distribution channel, 2020-2026 (USD Million)

7.4.8.3 Market size, by end-use, 2020-2026 (USD Million)

7.4.9 South Korea

7.4.9.1 Market size, by collection method, 2020-2026 (USD Million)

7.4.9.2 Market size, by distribution channel, 2020-2026 (USD Million)

7.4.9.3 Market size, by end-use, 2020-2026 (USD Million)

7.5 Latin America

7.5.1 Market size, by country 2020-2026 (USD Million)

7.5.2 Market size, by collection method, 2020-2026 (USD Million)

7.5.3 Market size, by distribution channel, 2020-2026 (USD Million)

7.5.4 Market size, by end-use, 2020-2026 (USD Million)

7.5.5 Brazil

7.5.5.1 Market size, by collection method, 2020-2026 (USD Million)

7.5.5.2 Market size, by distribution channel, 2020-2026 (USD Million)

7.5.5.3 Market size, by end-use, 2020-2026 (USD Million)

7.5.6 Mexico

7.5.6.1 Market size, by collection method, 2020-2026 (USD Million)

7.5.6.2 Market size, by distribution channel, 2020-2026 (USD Million)

7.5.6.3 Market size, by end-use, 2020-2026 (USD Million)

7.6 MEA

7.6.1 Market size, by country 2020-2026 (USD Million)

7.6.2 Market size, by collection method, 2020-2026 (USD Million)

7.6.3 Market size, by distribution channel, 2020-2026 (USD Million)

7.6.4 Market size, by end-use, 2020-2026 (USD Million)

7.6.5 Saudi Arabia

7.6.5.1 Market size, by collection method, 2020-2026 (USD Million)

7.6.5.2 Market size, by distribution channel, 2020-2026 (USD Million)

7.6.5.3 Market size, by end-use, 2020-2026 (USD Million)

7.6.6 UAE

7.6.6.1 Market size, by collection method, 2020-2026 (USD Million)

7.6.6.2 Market size, by distribution channel, 2020-2026 (USD Million)

7.6.6.3 Market size, by end-use, 2020-2026 (USD Million)

7.6.7 South Africa

7.6.7.1 Market size, by collection method, 2020-2026 (USD Million)

7.6.7.2 Market size, by distribution channel, 2020-2026 (USD Million)

7.6.7.3 Market size, by end-use, 2020-2026 (USD Million)

Chapter 8 Company Landscape

8.1 Competitive analysis, 2020

8.2 Quidel

8.2.1 Company overview

8.2.2 Financial analysis

8.2.3 Strategic positioning

8.2.4 Info graphic analysis

8.3 Cue Health Inc.

8.3.1 Company overview

8.3.2 Financial analysis

8.3.3 Strategic positioning

8.3.4 Info graphic analysis

8.4 Trivitron

8.4.1 Company overview

8.4.2 Financial analysis

8.4.3 Strategic positioning

8.4.4 Info graphic analysis

8.5 Lucira Health

8.5.1 Company overview

8.5.2 Financial analysis

8.5.3 Strategic positioning

8.5.4 Info graphic analysis

8.6 Ellume Health

8.6.1 Company overview

8.6.2 Financial analysis

8.6.3 Strategic positioning

8.6.4 Info graphic analysis

8.7 Abbott

8.7.1 Company overview

8.7.2 Financial analysis

8.7.3 Strategic positioning

8.7.4 Info graphic analysis

8.8 Labcorp

8.8.1 Company overview

8.8.2 Financial analysis

8.8.3 Strategic positioning

8.8.4 Info graphic analysis

8.9 EverlyWell

8.9.1 Company overview

8.9.2 Financial analysis

8.9.3 Strategic positioning

8.9.4 Info graphic analysis

8.10 LetsGetChecked

8.10.1 Company overview

8.10.2 Financial analysis

8.10.3 Strategic positioning

8.10.4 Info graphic analysis

8.11 Phosphorus

8.11.1 Company overview

8.11.2 Financial analysis

8.11.3 Strategic positioning

8.11.4 Info graphic analysis

8.12 Hims & Hers

8.12.1 Company overview

8.12.2 Financial analysis

8.12.3 Strategic positioning

8.12.4 Info graphic analysis

8.13 Picture by Fulgent Genetics

8.13.1 Company overview

8.13.2 Financial analysis

8.13.3 Strategic positioning

8.13.4 Info graphic analysis

8.14 Vitagene

8.14.1 Company overview

8.14.2 Financial analysis

8.14.3 Strategic positioning

8.14.4 Info graphic analysis

8.15 Mylab

8.15.1 Company overview

8.15.2 Financial analysis

8.15.3 Strategic positioning

8.15.4 Info graphic analysis

8.16 Healgen Scientific

8.16.1 Company overview

8.16.2 Financial analysis

8.16.3 Strategic positioning

8.16.4 Info graphic analysis

8.17 Xiamen Boson Biotech

8.17.1 Company overview

8.17.2 Financial analysis

8.17.3 Strategic positioning

8.17.4 Info graphic analysis

8.18 Hangzhou Laihe Biotech

8.18.1 Company overview

8.18.2 Financial analysis

8.18.3 Strategic positioning

8.18.4 Info graphic analysis

8.19 Eurofins

8.19.1 Company overview

8.19.2 Financial analysis

8.19.3 Strategic positioning

8.19.4 Info graphic analysis

8.20 Megna Health

8.20.1 Company overview

8.20.2 Financial analysis

8.20.3 Strategic positioning

8.20.4 Info graphic analysis

8.21 Therma Bright

8.21.1 Company overview

8.21.2 Financial analysis

8.21.3 Strategic positioning

8.21.4 Info graphic analysis

8.22 My Health Checked

8.22.1 Company overview

8.22.2 Financial analysis

8.22.3 Strategic positioning

8.22.4 Info graphic analysis

8.23 OraSure technologies

8.23.1 Company overview

8.23.2 Financial analysis

8.23.3 Strategic positioning

8.23.4 Info graphic analysis

8.24 Roche

8.24.1 Company overview

8.24.2 Financial analysis

8.24.3 Strategic positioning

8.24.4 Info graphic analysis

8.25 City Health

8.25.1 Company overview

8.25.2 Financial analysis

8.25.3 Strategic positioning

8.25.4 Info graphic analysis

8.26 Nanomix

8.26.1 Company overview

8.26.2 Financial analysis

8.26.3 Strategic positioning

8.26.4 Info graphic analysis

The Global Over The Counter & Remote Test For Covid-19 Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Over The Counter & Remote Test For Covid-19 Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe. Privacy

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

What is the projected market size of the global over-the-counter & remote test for COVID-19 market?

The global over-the-counter & remote test for COVID-19 market size is projected to grow from USD xx million in 2021 to USD xx million by 2026 at a CAGR value of xx%.

Who are the major vendors in the over-the-counter & remote test for the COVID-19 market?

Key and innovative vendors in the over-the-counter & remote test for COVID-19 market include Quidel, Cue Health Inc., Lucira Health, Ellume Health, Abbott, Healgen Scientific, Xiamen Boson Biotech, Hangzhou Laihe Biotech, Eurofins, Megna Health, Therma Bright, My Health Checked, OraSure technologies, Roche, City Health, Trivitron, Mylab, Labcorp, and Nanomix, among others.

Which region has the highest market share in the over-the-counter & remote test for COVID-19 market?

The North American region is estimated to hold the largest share of the over-the-counter & remote test for COVID-19 market.

What is the Covid-19 impact on future over-the-counter & remote tests for COVID-19 manufacturers?

The pandemic has increased demand for remote testing kits and as the world returns to normalcy, the demand for testing kits is only expected to rise as the healthcare organization’s priority will turn towards management of the spread of the virus.

What are the major drivers in the over-the-counter & remote test for COVID-19 market?

Rapid FDA approvals for testing kits, an increasing number of people opting for at-home COVID-19 tests, increasing number of international work trips, and growing number of home based COVID test kit players in the market, and the large investment in the development of novel testing kits and methods are expected to be the key drivers of the market.